CompaniesGemin X

Gemin X

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (13)
View all

Total Trials

13

As Lead Sponsor

12

As Collaborator

1

Total Enrollment

447

By Phase

PHASE2: 6PHASE1/PHASE2: 4PHASE1: 3

By Status

COMPLETED: 10TERMINATED: 2WITHDRAWN: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00438178
Hover over trial bars to see details

Recent Trials

NCT00918931Collaborator
Obatoclax for Systemic Mastocytosis
PHASE2Terminated
3 participants
Started: Jun 30, 2009 · Completed: Oct 31, 2010
NCT00724841Lead Sponsor
A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma
PHASE1/PHASE2Terminated
1 participants
Started: Jun 30, 2008 · Completed: Aug 31, 2010
NCT00682981Lead Sponsor
A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
PHASE1/PHASE2Completed
218 participants
Started: May 31, 2008 · Completed: Nov 30, 2011
NCT00684918Lead Sponsor
Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)
PHASE2Completed
18 participants
Started: Apr 30, 2008 · Completed: Dec 31, 2009
NCT00427856Lead Sponsor
Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)
PHASE2Completed
7 participants
Started: Mar 31, 2007 · Completed: Jul 31, 2009
View all 13 trials →
Funding History (2)
D
May 14, 2010
Filing
D
Jun 12, 2009
Filing
Related Companies
Cephalon Mar 2011----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired